France · Source-listed medicine information

France / CIS 61106121

SULFATE DE MAGNESIUM LAVOISIER 15 POUR CENT (0,15 g/ml), solution injectable (I.V.) en ampoule

solution injectable · intraveineuse

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formsolution injectable
Routeintraveineuse
Ingredient entries1
CountryFrance

Product identity

At a glance

Authorisation holder
LABORATOIRES CHAIX ET DU MARAIS
Authorisation status
Autorisation active
Market status
Commercialisée
Country
France
Source reference
CIS 61106121

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for SULFATE DE MAGNESIUM LAVOISIER 15 POUR CENT (0,15 g/ml), solution injectable (I.V.) en ampoule
IngredientStrength / referenceSource role
SULFATE DE MAGNÉSIUM HEPTAHYDRATÉsolution0,15 g1 ml de solution injectableSAGroup 1

Pack references

Presentations (4)

10 ampoule(s) bouteille en verre de 10 ml

CIP13 3400936299801

Présentation active · Déclaration d'arrêt de commercialisation
10 ampoule(s) bouteille en verre de 20 ml

CIP13 3400936299979

Présentation active · Déclaration de commercialisation
100 ampoule(s) polypropylène de 10 ml

CIP13 3400955026600

Présentation active · Déclaration de commercialisation
100 ampoule(s) bouteille en verre de 10 ml

CIP13 3400956478125

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 61106121 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source fileRetrievedSource file modified
fr_products.txtNot supplied
fr_composition.txtNot supplied
fr_packs.txtNot supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →